Bradley Ottinger - 16 Mar 2023 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: General Counsel and CCO
Issuer ticker: AXGN
Reported as of: 16 Mar 2023
Net transaction value: -$21,783
SEC form: 4
Accepted by SEC: 20 Mar 2023, 18:50:24 UTC
Prior SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Bradley Ottinger

Key filing fact

Bradley Ottinger filed Form 4 for Axogen, Inc. (AXGN) on 20 Mar 2023.

Key facts

This page summarizes Bradley Ottinger's Form 4 filing for Axogen, Inc. (AXGN).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 20 Mar 2023, 18:50.

Change

Previous filing in this sequence was filed on 03 Jun 2022.
Current net transaction value: -$21,783.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +5,900
Change %: +33%
Price: $0.000000
Shares after: 23,698
Date: 16 Mar 2023
Ownership: Direct
Footnotes: F1, F2

AXGN transaction

Common Stock

Tax liability

Transaction value: $6,599
Shares: -798
Change %: -3.4%
Price: $8.27
Shares after: 22,900
Date: 16 Mar 2023
Ownership: Direct
Footnotes: F3

AXGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,563
Change %: +11%
Price: $0.000000
Shares after: 25,463
Date: 16 Mar 2023
Ownership: Direct
Footnotes: F1

AXGN transaction

Common Stock

Tax liability

Transaction value: $15,184
Shares: -1,836
Change %: -7.2%
Price: $8.27
Shares after: 23,627
Date: 16 Mar 2023
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -5,900
Change %: -50%
Price: $0.000000
Shares after: 5,900
Date: 16 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,900
Exercise price
Footnotes: F4, F5

AXGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,563
Change %: -50%
Price: $0.000000
Shares after: 2,564
Date: 16 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,563
Exercise price
Footnotes: F4, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Bradley Ottinger is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

This reflects the number of restricted stock units that became vested as of March 16, 2023.

Footnote F2

Includes 3,000 shares acquired under the Axogen stock purchase plan in 2022.

Footnote F3

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

Footnote F5

All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.

Footnote F6

All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (3 years from the grant date) based upon a vesting schedule whereby 33.33% of the aggregate shares vest on March 16, 2022, 33.33% of the aggregate shares vest on March 16, 2023, and 33.34% of the aggregate shares vest on March 16, 2024. Vested shares will be delivered to the reporting person upon the vesting date.